![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
DC Manning, R Vavrek, JM Stewart and SH Snyder
Bradykinin (BK) and related peptides exert a wide range of effects on several organ systems. We have attempted to sort out these effects by studying the binding interaction of [3H]BK at the membrane level with in vitro receptor binding techniques. High specific activity [3H]BK and an enzyme inhibitor "cocktail" has enabled us to label two BK binding sites with different affinity and peptide specificity in several guinea- pig tissues. In the guinea-pig ileum the high-affinity site has an equilibrium dissociation constant (Kd) for [3H]BK of 13 pM and a maximal number of binding sites of 8.3 pmol/g of tissue wet weight. The low-affinity guinea-pig ileum site displays a Kd of 910 pM, a maximum number of binding sites of 14 pmol/g of tissue wet weight and shows a greater selectivity for BK analogs over Lysyl-BK analogs. Two similar sites can also be discriminated in kidney and heart. The potencies of a series of BK analogs at the high-affinity guinea-pig ileum site correlate well with their potencies in contracting ileal smooth muscle. The binding of [3H]BK in the guinea-pig ileum is inhibited by physiological concentrations of monovalent and divalent cations.
This article has been cited by other articles:
|
|
 |
|
  M. F. Otuki, J. Ferreira, F. V. Lima, C. Meyre-Silva, A. Malheiros, L. A. Muller, G. S. Cani, A. R. S. Santos, R. A. Yunes, and J. B. Calixto Antinociceptive Properties of Mixture of {alpha}-Amyrin and {beta}-Amyrin Triterpenes: Evidence for Participation of Protein Kinase C and Protein Kinase A Pathways J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 310 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Gougat, B. Ferrari, L. Sarran, C. Planchenault, M. Poncelet, J. Maruani, R. Alonso, A. Cudennec, T. Croci, F. Guagnini, et al. SSR240612 [(2R)-2-[((3R)-3-(1,3-Benzodioxol-5-yl)-3-{[(6-methoxy-2-naphthyl)sulfonyl]amino}propanoyl)amino]-3-(4-{[2R,6S)-2,6-dimethylpiperidinyl]methyl}phenyl)-N-isopropyl-N-methylpropanamide Hydrochloride], a New Nonpeptide Antagonist of the Bradykinin B1 Receptor: Biochemical and Pharmacological Characterization J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 661 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. M. Castano, J. P. Schanstra, C. Hirtz, J. B. Pesquero, C. Pecher, J.-P. Girolami, and J.-L. Bascands B2 kinin receptor upregulation by cAMP is associated with BK-induced PGE2 production in rat mesangial cells Am J Physiol Renal Physiol, March 1, 1998; 274(3): F532 - F540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Aramori, J. Zenkoh, N. Morikawa, N. O'Donnell, M. Asano, K. Nakamura, M. Iwami, H. Kojo, and Y. Notsu Novel Subtype-Selective Nonpeptide Bradykinin Receptor Antagonists FR167344 and FR173657 Mol. Pharmacol., February 1, 1997; 51(2): 171 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.-z. Wang, L. Chao, and J. Chao Hypotension in Transgenic Mice Overexpressing Human Bradykinin B2 Receptor Hypertension, January 1, 1997; 29(1): 488 - 493. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
